Technolution becomes MGS Design & Development, enhancing end-to-end solutions for healthcare innovators.
GERMANTOWN, Wis (September 23, 2025) – MGS, a global contract development and manufacturing organization (CDMO) for healthcare products, announced today the official transition of Technolution to the MGS name, aligning the team’s specialized design and development capabilities within the company’s global brand. Now operating as MGS, the former Technolution team continues to lead the company’s design and development efforts, advancing early-stage innovation as part of MGS’ end-to-end offering for Pharmaceutical, Diagnostic and MedTech customers.
The Design & Development team brings deep expertise across many disciplines related to product development – all competencies within R&D combined with regulatory, quality, and project management. With a flexible, consultancy-driven approach, they support customers at every level, from a single area of competence to full-scale product design and development. These strengths integrate directly with MGS’ global capabilities in tooling, automation and manufacturing to create a seamless, vertically integrated value chain.
“Our Design & Development team has always brough curiosity, creativity and precision to the front end of product development and innovation,” said Paul Manley, President & CEO of MGS. “Across all of MGS’ global teams, we share a commitment to solving complex challenges with speed and care. Now, as one brand, we’re making that expertise even more accessible by connecting it across the full product lifecycle.”
This brand alignment reinforces MGS’ commitment to reducing risk, accelerating timelines and supporting better outcomes through tightly connected, cross-functional collaboration. The unified approach gives customers the speed and agility of a true partner, along with direct access to executive decision makers who can move quickly and think strategically to drive customer growth.
“We are proud to bring our design and development expertise more fully into the MGS brand,” said Thomas Bach Agerslev, Vice President of MGS Design & Development and former CEO of Technolution. “Our team is still the same approachable, high-performing group of people our clients know – curious, collaborative and, yes, still nice and nerdy. This change reflects how we already work and makes it even easier for customers to access our end-to-end solutions closer to where they do business.”
The MGS Design & Development team remains based in Horsholm, Denmark, with expanded presence in Boston to support North American clients. Their people, processes and partnership-first mindset remain unchanged – now backed by the broader MGS platform and global resources.
To learn more, visit https://www.mgsmfg.com/welcome-technolution/.
About MGS
MGS is a global contract development and manufacturing organization (CDMO) that helps healthcare innovators bridge the gap between imagination and realization. For leading Pharmaceutical, Diagnostic and MedTech companies, MGS accelerates the delivery of transformative solutions by combining robust, vertically integrated capabilities with the agility and focus of a true partner. From first sketch to final solution, the MGS team brings deep expertise, advanced technology and a collaborative mindset to every stage of the development lifecycle. With 12 locations across North America and Europe, MGS empowers customers to reduce risk, move faster and improve lives around the world. Learn more at mgsmfg.com.
